Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec;22(6):T187-97.
doi: 10.1530/ERC-15-0195. Epub 2015 Aug 25.

The many ways to make a luminal cell and a prostate cancer cell

Affiliations
Review

The many ways to make a luminal cell and a prostate cancer cell

Douglas W Strand et al. Endocr Relat Cancer. 2015 Dec.

Abstract

Research in the area of stem/progenitor cells has led to the identification of multiple stem-like cell populations implicated in prostate homeostasis and cancer initiation. Given that there are multiple cells that can regenerate prostatic tissue and give rise to prostate cancer, our focus should shift to defining the signaling mechanisms that drive differentiation and progenitor self-renewal. In this article, we will review the literature, present the evidence and raise important unanswered questions that will help guide the field forward in dissecting critical mechanisms regulating stem-cell differentiation and tumor initiation.

Keywords: carcinoma; prostate.

PubMed Disclaimer

Conflict of interest statement

Declaration of interest

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the review.

Figures

Figure 1
Figure 1
Model of prostate epithelial homeostasis and cancer initiation. In the benign prostate, basal cells and luminal cells predominantly self-renew to make more of themselves, while rare basal cells differentiate into the luminal lineage. Upon basal cell transformation, basal to luminal differentiation is enhanced and cancers become driven by tumorigenic luminal cells in the absence of the initiating basal cells. Luminal transformation rapidly gives rise to tumorigenic luminal cells.

References

    1. Abate-Shen C, Shen MM. Molecular genetics of prostate cancer. Genes and Development. 2000;14:2410–2434. - PubMed
    1. Ali TZ, Epstein JI. Basal cell carcinoma of the prostate: a clinicopathologic study of 29 cases. American Journal of Surgical Pathology. 2007;31:697–705. - PubMed
    1. Antonarakis ES, Lu C, Wang H, Luber B, Nakazawa M, Roeser JC, Chen Y, Mohammad TA, Chen Y, Fedor HL, et al. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. New England Journal of Medicine. 2014;371:1028–1038. - PMC - PubMed
    1. Ayala G, Tuxhorn JA, Wheeler TM, Frolov A, Scardino PT, Ohori M, Wheeler M, Spitler J, Rowley DR. Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. Clinical Cancer Research. 2003;9:4792–4801. - PubMed
    1. Bauman TM, Vezina CM, Huang W, Marker PC, Peterson RE, Ricke WA. Beta-catenin is elevated in human benign prostatic hyperplasia specimens compared to histologically normal prostate tissue. American Journal of Clinical and Experimental Urology. 2014;2:313–322. - PMC - PubMed

MeSH terms